MedTrace Logo

The Role of Extracorporeal Shock Wave Therapy in the Treatment of Trapezial-Metacarpal Osteoarthritis. A Double Blind Randomized Controlled Study.

NCT01783262 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2013-02-04

No results posted yet for this study

Summary

Evaluate if extracorporeal shock wave therapy is more effective than sham treatment in patients with trapezial-metacarpal osteoarthritis in pain relief and functional improvement.

Conditions

  • Osteoarthritis Trapezial-metacarpal Joint

Interventions

DEVICE

Extracorporeal shock wave therapy STORZ MEDICAL Modulith SLK

an energy level of 0.09 mJ/mm2, 2400 pulses once a week for 4 weeks.

DEVICE

Device: Sham extracorporeal shock wave therapy STORZ MEDICAL Modulith SLK

Sponsors & Collaborators

  • University of Roma La Sapienza

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2011-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01783262 on ClinicalTrials.gov